These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9188091)

  • 1. Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates.
    Klee SR; Tzschaschel BD; Singh M; Fält I; Lindberg AA; Timmis KN; Guzmán CA
    Microb Pathog; 1997 Jun; 22(6):363-76. PubMed ID: 9188091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.
    Klee SR; Tzschaschel BD; Fält I; Kärnell A; Lindberg AA; Timmis KN; Guzmán CA
    Infect Immun; 1997 Jun; 65(6):2112-8. PubMed ID: 9169740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.
    Fält IC; Schweda EK; Klee S; Singh M; Floderus E; Timmis KN; Lindberg AA
    J Bacteriol; 1995 Sep; 177(18):5310-5. PubMed ID: 7545156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
    Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Shigella flexneri serotype Y vaccine candidate SFL124 originated from a serotype 2a background.
    Roberts F; Jennison AV; Verma NK
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):285-9. PubMed ID: 15963704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of recombinant aroA salmonellae stably producing the Shigella dysenteriae serotype 1 O-antigen and structural characterization of the Salmonella/Shigella hybrid LPS.
    Fält IC; Mills D; Schweda EK; Timmis KN; Lindberg AA
    Microb Pathog; 1996 Jan; 20(1):11-30. PubMed ID: 8692007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of different rol gene products on the chain length of Shigella dysenteriae type 1 lipopolysaccharide O antigen expressed by Shigella flexneri carrier strains.
    Klee SR; Tzschaschel BD; Timmis KN; Guzman CA
    J Bacteriol; 1997 Apr; 179(7):2421-5. PubMed ID: 9079931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1.
    Fontaine A; Arondel J; Sansonetti PJ
    Res Microbiol; 1990; 141(7-8):907-12. PubMed ID: 2101481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection.
    Xu DQ; Cisar JO; Osorio M; Wai TT; Kopecko DJ
    Vaccine; 2007 Aug; 25(33):6167-75. PubMed ID: 17629369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of S.sonnei form I antigen gene and V.cholerae toxin B subunit gene in S.flexneri 2a strain and investigation of their immunoprotective response in mice].
    Qian F; Rui X; Su G; Huang C
    Yi Chuan Xue Bao; 1996; 23(4):322-8. PubMed ID: 8950856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine potential for inactivated shigellae.
    Osorio M; Bray MD; Walker RI
    Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a.
    Liu Q; Su H; Bian X; Wang S; Kong Q
    Int J Med Microbiol; 2020 Jul; 310(5):151427. PubMed ID: 32654768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide O-antigen biosynthesis in Shigella dysenteriae serotype 1: analysis of the plasmid-carried rfp determinant.
    Göhmann S; Manning PA; Alpert CA; Walker MJ; Timmis KN
    Microb Pathog; 1994 Jan; 16(1):53-64. PubMed ID: 7520113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype conversion of a Shigella flexneri candidate vaccine strain via a novel site-specific chromosome-integration system.
    Guan S; Verma NK
    FEMS Microbiol Lett; 1998 Sep; 166(1):79-87. PubMed ID: 9741086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
    Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
    J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.